Claus Bang Pedersen

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

Priscilla Hollander, John Cooper, Jesper Flethøj Bregnhøj et al. · Clinical Therapeutics · 2008 · 162 citations

Obesity, Diabetes Management, Insulin Glargine +8

Reduced Weight Gain with Insulin Detemir Compared to NPH Insulin Is Not Explained by a Reduction in Hypoglycemia

Melanie J. Davies, Tadeusz Dereziński, Claus Bang Pedersen et al. · Diabetes Technology & Therapeutics · 2008 · 47 citations

A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris

Victoria Taraska, Raj Tuppal, Martin Olesen et al. · Journal of Cutaneous Medicine and Surgery · 2015 · 35 citations · Full text

Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris

Claus Bang Pedersen, Colleen A. McHorney, Lotte Seiding Larsen et al. · Journal of Dermatological Treatment · 2016 · 19 citations

<i>In vivo</i> characterization of structural changes after topical application of glucocorticoids in healthy human skin

Sora Jung, Jürgen Lademann, Maxim E. Darvin et al. · Journal of Biomedical Optics · 2017 · 17 citations · Full text

Ophthalmology, Medicine, Cutaneous Biology +15